Chengdu Kanghong Pharmaceutical Group Co., Ltd.

This clinical trial is testing an experimental oral medication called KH607 in adults with major depressive disorder. Participants will receive either KH607 or a placebo once daily for several weeks, and researchers will measure changes in depression severity using a standard rat…

This clinical trial is testing an investigational drug called KH607 in adults with major depressive disorder (MDD). The study compares KH607 against an existing antidepressant, vortioxetine, to see which is more effective at reducing depression symptoms. Participants will take ei…

This early-stage trial tests a new oral drug called KHN702 for moderate to severe pain after surgery. About 24 adults will receive either the drug or a placebo to see if it is safe and helps reduce pain. The study is double-blind, meaning neither patients nor doctors know who get…

This study looks at how a high-fat meal changes the way KH607 tablets are absorbed in the body. Sixteen healthy Chinese adults will take the drug once on an empty stomach and once after a fatty meal to compare the effects. The goal is to understand food's impact on the drug and c…

This early-stage study tests whether KHN707 tablets are safe and how the body processes them. About 38 healthy Chinese adults aged 18-45 will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease…